Tradestie Institutional Equity Comparison Engine

ACA vs PUSA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ACA Overall Edge

ACA Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Arcosa, Inc. Common Stock (ACA) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ACA trades at 29.1x Forward P/E with 12.3% operating margin (+1.7% YoY revenue) versus PUSA at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ACA sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro) against PUSA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ACA
ACA 29.1x vs PUSA N/M Fwd P/E
Growth & Margin Winner ACA
Op Margin 12.3% vs N/A ยท YoY +1.7% vs N/A
Momentum & Technical Winner ACA
1Y +57.4% vs -74.0% ยท 52W Pos 100% vs 2%
Options & Structure Winner ACA
UNCLASSIFIED (6th %ile IV) vs UNCLASSIFIED (N/A IV)
ACA NYSE
Arcosa, Inc. Common Stock
Fabricated Structural Metal Products
$149.15
+0.08% 1D
Market Cap $7.3B
1M Return +1.81%
1Y Return +57.43%
Forward P/E 29.1x
Unified AI Score
60.0 / 100 BUY
Tech 56.0 Fund 49.0 Flow 50.0 Mom 36.0
PUSA US Equity
PUSA
Institutional Equity
$1.12
+0.9% 1D
Market Cap N/A
1M Return -42.6%
1Y Return -74.02%
Forward P/E N/M
Unified AI Score
38.8 / 100 SELL
Tech 25.0 Fund 43.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ACA +57.43% PUSA -74.02% Spread: +76.86 pp (ACA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ACA TTM Op. Margin: 12.3% PUSA TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACA vs PUSA. Trailing 12-month operating profitability (ACA 12.3% vs PUSA N/A) and valuation multiples (ACA 29.1x vs PUSA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ACA (10) vs PUSA (0)
Institutional Metric ACA PUSA Criterion Row Winner
Market Capitalization Scale $7.3B N/A Larger Scale ACA
Trailing P/E Ratio Valuation 36.4x N/M Lower Multiple ACA
Forward P/E Ratio Valuation 29.1x N/M Lower Multiple ACA
Revenue Growth (YoY) Growth +1.7% N/A Higher Growth ACA
Operating Margin (TTM) Profitability 12.3% N/A Higher Margin ACA
Net Profit Margin Profitability 16.8% N/A Higher Margin ACA
Return on Equity (ROE) Capital Efficiency 8.0% N/A Higher ROE ACA
52-Week Range Position Momentum 100% ($91โ€“$149) 2% ($1โ€“$7) Stronger Trend ACA
Beta / 30D Volatility Risk Regime 0.92ฮฒ ยท 4% Vol 1.56ฮฒ ยท 105% Vol Lower Realized Risk ACA
Unified Institutional Score Composite Signal 60.0 / 100 (BUY) 38.8 / 100 (SELL) Higher Composite ACA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ACA vs PUSA Buy Guide
ACA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live ACA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PUSA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PUSA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ACA nor PUSA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.